• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nivolumab-associated cutaneous T-cell lymphoma.

作者信息

Marks Jennifer A, Parker Douglas C, Garrot L Crain, Lechowicz Mary Jo

机构信息

Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia.

Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.

出版信息

JAAD Case Rep. 2021 Jan 10;9:39-41. doi: 10.1016/j.jdcr.2020.12.033. eCollection 2021 Mar.

DOI:10.1016/j.jdcr.2020.12.033
PMID:33644277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7887609/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2038/7887609/bb11f3f60527/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2038/7887609/f9f72c8a31c8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2038/7887609/bb11f3f60527/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2038/7887609/f9f72c8a31c8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2038/7887609/bb11f3f60527/gr2.jpg

相似文献

1
Nivolumab-associated cutaneous T-cell lymphoma.纳武单抗相关的皮肤T细胞淋巴瘤。
JAAD Case Rep. 2021 Jan 10;9:39-41. doi: 10.1016/j.jdcr.2020.12.033. eCollection 2021 Mar.
2
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.原发性皮肤 T 细胞淋巴瘤（蕈样肉芽肿和赛泽里综合征）：第一部分。诊断：临床和组织病理学特征以及新的分子和生物学标志物。
J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049.
3
Cutaneous T-cell lymphoma and atopy: is there an association?皮肤T细胞淋巴瘤与特应性：存在关联吗？
Br J Dermatol. 2003 Nov;149(5):1013-7. doi: 10.1111/j.1365-2133.2003.05551.x.
4
Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.蕈样肉芽肿和 Sézary 综合征累及淋巴结，酷似血管免疫母细胞性 T 细胞淋巴瘤。
Hum Pathol. 2015 Sep;46(9):1382-9. doi: 10.1016/j.humpath.2015.05.024. Epub 2015 Jun 10.
5
Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.皮肤T细胞淋巴瘤：西非马里蕈样肉芽肿、塞扎里综合征及人嗜T淋巴细胞病毒I型相关成人T细胞白血病（ATL）：14例临床、病理及免疫病毒学研究并复习非洲ATL病例
Leukemia. 1998 Apr;12(4):578-85. doi: 10.1038/sj.leu.2400956.
6
Cutaneous T cell lymphoma in children.儿童皮肤T细胞淋巴瘤
Semin Cutan Med Surg. 1999 Sep;18(3):226-32. doi: 10.1016/s1085-5629(99)80020-0.
7
Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome.CCR3 和 CCR4 的表达提示蕈样肉芽肿和塞扎里综合征预后不良。
Acta Derm Venereol. 2019 Jul 1;99(9):809-812. doi: 10.2340/00015555-3207.
8
Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome.异基因造血细胞移植治疗蕈样肉芽肿后皮肤鳞状细胞癌对免疫检查点抑制的快速和持续反应。
J Immunother Cancer. 2019 Dec 4;7(1):338. doi: 10.1186/s40425-019-0801-z.
9
Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.蕈样肉芽肿/赛塞里综合征皮肤T细胞淋巴瘤患者生活质量的测量：一种电子仪器的开发
J Med Internet Res. 2019 Jan 7;21(1):e11302. doi: 10.2196/11302.
10
Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments.皮肤 T 细胞淋巴瘤的免疫治疗：现状与未来发展。
J Cutan Med Surg. 2019 Sep/Oct;23(5):537-544. doi: 10.1177/1203475419867610. Epub 2019 Jul 29.

引用本文的文献

1
Late-Onset Angioimmunoblastic T-cell Lymphoma During Nivolumab Treatment for Melanoma.黑色素瘤患者接受纳武单抗治疗期间发生的迟发性血管免疫母细胞性T细胞淋巴瘤
Cureus. 2025 Jul 30;17(7):e89042. doi: 10.7759/cureus.89042. eCollection 2025 Jul.
2
Engineered PD-L1 co-expression in PD-1 knockout and MAGE-C2-targeting TCR-T cells augments the cytotoxic efficacy toward target cancer cells.在程序性死亡蛋白-1（PD-1）敲除且靶向黑色素瘤相关抗原C2（MAGE-C2）的T细胞受体工程化T细胞（TCR-T细胞）中，工程化共表达程序性死亡受体配体1（PD-L1）可增强对靶癌细胞的细胞毒性作用。
Sci Rep. 2025 Apr 7;15(1):11894. doi: 10.1038/s41598-025-92209-z.
3
Development of Subcutaneous Panniculitis-Like T-cell Lymphoma After Immune Checkpoint Inhibitor Treatment.

本文引用的文献

1
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study.派姆单抗治疗复发/难治性蕈样霉菌病和塞扎里综合征：一项多中心 II 期研究。
J Clin Oncol. 2020 Jan 1;38(1):20-28. doi: 10.1200/JCO.19.01056. Epub 2019 Sep 18.
2
NCCN Guidelines Updates: Management of Metastatic Kidney Cancer.NCCN 指南更新：转移性肾癌的治疗管理。
J Natl Compr Canc Netw. 2019 May 1;17(5.5):587-589. doi: 10.6004/jnccn.2019.5008.
3
Adverse Effects of Immune Checkpoint Inhibitors (Programmed Death-1 Inhibitors and Cytotoxic T-Lymphocyte-Associated Protein-4 Inhibitors): Results of a Retrospective Study.
免疫检查点抑制剂治疗后皮下脂膜炎样T细胞淋巴瘤的发生
Cureus. 2024 Aug 15;16(8):e66974. doi: 10.7759/cureus.66974. eCollection 2024 Aug.
4
PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma.PD-1 指令性肿瘤抑制代谢程序，限制糖酵解和抑制 T 细胞淋巴瘤中的 AP-1 活性。
Nat Cancer. 2023 Oct;4(10):1508-1525. doi: 10.1038/s43018-023-00635-7. Epub 2023 Sep 18.
5
STING expression is an independent prognostic factor in patients with mycosis fungoides.STING 表达是蕈样肉芽肿患者的独立预后因素。
Sci Rep. 2022 Jul 26;12(1):12739. doi: 10.1038/s41598-022-17122-1.
6
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives.原发性皮肤T细胞淋巴瘤中的免疫检查点抑制剂：生物学原理、临床结果及未来展望
Front Oncol. 2021 Aug 16;11:733770. doi: 10.3389/fonc.2021.733770. eCollection 2021.
免疫检查点抑制剂（程序性死亡-1抑制剂和细胞毒性T淋巴细胞相关蛋白-4抑制剂）的不良反应：一项回顾性研究的结果
J Clin Med Res. 2019 Apr;11(4):225-236. doi: 10.14740/jocmr3750. Epub 2019 Mar 18.
4
Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapy.抗肿瘤坏死因子-α治疗后未诊断的皮肤淋巴瘤进展。
J Am Acad Dermatol. 2018 Jun;78(6):1068-1076. doi: 10.1016/j.jaad.2017.12.068. Epub 2018 Jan 4.
5
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.纳武利尤单抗治疗复发或难治性血液系统恶性肿瘤患者：Ib期研究的初步结果
J Clin Oncol. 2016 Aug 10;34(23):2698-704. doi: 10.1200/JCO.2015.65.9789. Epub 2016 Jun 6.
6
Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).蕈样肉芽肿/赛泽里综合征：免疫发病机制、治疗选择的文献综述，以及美国皮肤淋巴瘤联合会（USCLC）的治疗建议。
J Am Acad Dermatol. 2011 Feb;64(2):352-404. doi: 10.1016/j.jaad.2010.08.037. Epub 2010 Dec 9.